Increased expression and increased function of mitochondrial HSP90, as observed in some cancers, lead to sufficient ATP production in nutrient-scarce tumor cells to avoid triggering activation of the LKB1-AMPK pathway. This evidence concerns the gene HSP90AB1 and neoplasm.